Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
opioid
5
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
5
×
wisconsin top stories
cancer
clinical trials
deals
drug prices
startups
abbvie
bristol-myers squibb
cancer immunotherapy
celgene
cell therapy
crisis
duchenne muscular dystrophy
What
roundup
bio
drug
ahead
approval
asco
conference
abbvie’s
advanced
alnylam’s
ambien
american
annual
attendees
attention
barbecuing
bff
biogen’s
biopharmaceutical
biotech
branded
camping
camp’s
cancer
cardiologist
cash
center
check
chicago
choices
cholesterol
city
clinical
combinations
commissioner
community’s
companies
consumers
convo
costly
Language
unset
Current search:
opioid
×
" wisconsin blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
